Associate Professor Jan Beyer-Westendorf
Heart Centre Dresden - Dresden Technical University Hospital, Dresden (Germany)
Two-year outcomes of patients with atrial fibrillation treated with rivaroxaban: results from RIVER registry
Event: ESC Congress 2021 - The Digital Experience
Topic: Oral Anticoagulation
Session: Atrial fibrillation e-posters
Beyond real word evidence: learnings from databases and registers
Event: ESC Congress 2019
Topic: Cardio-Oncology
Session: NOACs in cancer associated thrombosis: managing anticoagulation in cancer patients in clinical practice
Thrombotic events in bleeding patients treated with andexanet alfa: an ANNEXA-4 sub-study
Event: ESC Congress 2019
Topic: Clinical
Session: Interventions for stroke: From prevention to acute treatment
What do the data say about stroke prevention and renal impairment?
Event: ESC Congress 2018
Topic: Prevention
Session: Translating real world evidence into your clinical practice for your multi-morbid patient
From study to the clinic... Does consistency of outcome matter.
Event: ESC Congress 2017
Topic: Atrial fibrillation (AF)
Session: The novel oral anticoagulants (NOACS)... From clinical theory to clinical practice - The value of consistency of outcome
Making sense of the data.
Event: ESC Congress 2017
Topic: Atrial fibrillation (AF)
Session: From clinical theory to clinical practice... Phase lll studies of the novel oral anticoagulants (NOACs) to real world evidence (RWE)
Evaluating the prospective RWE registries... The rules.
Event: ESC Congress 2017
Topic: Atrial fibrillation (AF)
Session: From clinical theory to clinical practice... Phase lll studies of the novel oral anticoagulants (NOACs) to real world evidence (RWE)
The CHA2DS2-VASc score strongly correlates with glomerular filtration rate and predicts decline in renal function over time in patients with atrial fibrillation and chronic kidney disease
Event: ESC Congress 2016
Topic: Atrial fibrillation (AF)
Session: Clinical features and management of atrial fibrillation
ESC 365 is supported by
